A new coronavirus, 2019-nCoV, related to the SARS and MERS diseases that have caused epidemics, has been discovered in China and started to spread. There are, till now, no vaccines or antiviral drugs that are approved for prevention or treatment of the new virus. People without symptoms can infect others. With such asymptomatic cases and these individuals can spread the virus, then containing its spread will be much more difficult. The more it multiplies, the more cases there are and the risk of mutation increases. There is also a risk of virus recombination, the formation of a new variety of viruses resulting from the genetic mixture of two nearby viruses. Since this is an RNA virus, it will continue to mutate as long as it continues to circulate in humans.
Activation of macrophages represents one of the first events in the innate response. The mechanisms of innate and adaptive immunity are, however, interdependent. This intercommunication is also performed through macrophages, which participate in the production, mobilization, activation and regulation of all effector cells of the immune system. The components of innate immunity are mechanical barriers, secreted products, and include mononuclear phagocytes and Natural Killer Cells. The innate immune response not only exerts an important protective function but also serves to initiate and regulate the subsequent acquired immune response. MODUL8 is not a vaccine but can prevent the 2019-nCoV contamination, activating the Innate Immune System, so the virus can mutate or recombine, but even so macrophages, CD8 cells, NK cells, can recognize the cells-bearing virus.
How can MODUL8 Complex protect us against a mutant or recombinant virus such as the 2019-nCoV? BY ACTIVATING OUR INNATE IMMUNE SYSTEM!
Diagram showing effects of MODUL8 over Immune System:
Prof. Dr. Dorly de Freitas Buchi